Leukocyte depleting filter attenuates myocardial injury during elective coronary artery bypass surgery

Scand Cardiovasc J. 2005 Dec;39(6):358-68. doi: 10.1080/14017430510035943.

Abstract

Background: Ischemia-reperfusion injury secondary to leukocyte activation has been widely recognized as one of the most relevant mechanism leading to postoperative organ dysfunction occurring after a period of ischemia. The aim of the present study was to evaluate in a prospective, randomized study, the value of leukocyte depleting filter in patients undergoing elective coronary artery bypass surgery.

Methods: Twenty patients scheduled for elective on-pump coronary artery bypass surgery were randomized to undergo cardiopulmonary bypass either with a leukocyte depleting filter incorporated in the extracorporeal circulation arterial line or without a filter.

Results: The main finding of this study was the significantly lower postoperative concentrations of cardiac troponin I in the leukocyte filter group (Tests of between-subjects effects: p = 0.024). There were also slightly better cardiac indices in the leukocyte filter group. A larger amount of blood units was infused intra- and postoperatively in patients undergoing cardiopulmonary bypass with leukocyte filtration (median, 600 [IQR, 0-1200] vs. 0 [IQR, 0-600], p = 0.08). Two patients in the leukocyte filter group underwent reoperation for bleeding but none in the control group (p = 0.48). Intra-and postoperative platelet count was lower in the leukocyte filter group (Tests of between-subjects effects: p = 0.08). Despite a significant increased concentration of C-reactive protein on the first postoperative day in the control group (p = 0.029), repeated-measures analysis failed to show any significant increase during the study period (p = 0.33).

Conclusions: The results of this study suggest a myocardial protective effect of leukocyte filter in the setting of elective coronary artery bypass surgery.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Aged
  • C-Reactive Protein
  • Cardiopulmonary Bypass / adverse effects
  • Cardiopulmonary Bypass / instrumentation
  • Cardiopulmonary Bypass / methods*
  • Coronary Artery Bypass / adverse effects
  • Coronary Artery Bypass / methods*
  • Elective Surgical Procedures
  • Female
  • Hemodynamics
  • Hemofiltration*
  • Humans
  • Leukocytes*
  • Male
  • Myocardial Reperfusion Injury / prevention & control*
  • Myocardium / pathology*
  • Prospective Studies
  • Risk Factors

Substances

  • C-Reactive Protein